#USA #Patient Access #Valeris #Fuze Health #Jeffersonville, IN

Valeris and Fuze Health Collaborate to Enhance Patient Access Model

In a significant development in the life sciences sector, Valeris, a comprehensive life sciences commercialization partner, has announced a collaboration with Fuze Health, known for its tech-driven healthcare solutions. This partnership seeks to modernize the patient access model in healthcare by incorporating advanced digital pharmacy capabilities alongside access, affordability, and patient support services.

This joint effort was unveiled during the Asembia's AX26 Summit held in Las Vegas, emphasizing a shared goal to redefine market access through data and technology. Both entities aim to create a connected, efficient, and scalable model that focuses on improving patient outcomes, speeding up interaction, and refining coordination throughout the patient care journey.

Transforming the Patient Experience

Robert Truckenmiller, the CEO of Valeris, expressed the company’s commitment to enhancing patient access to care: "Our mission is to ensure that patients experience faster, easier access to necessary therapies with robust support. This collaboration represents a meaningful stride toward achieving that vision with integrated solutions combining digital pharmacy and patient access."

Paul Greenall, CEO of FuzeRx (the pharmacy services division of Fuze Health), echoed these sentiments, stating, "Together with Valeris, we are dedicated to expanding access to critical therapies and innovating the entire patient experience. Our combined capabilities will translate into improved support for pharmaceutical manufacturers in enhancing provider and patient interactions."

A Seamless Operating Model

At the core of this collaboration is a streamlined operating model that seamlessly integrates digital pharmacy workflows with patient access services. Under the umbrella of Fuze Health’s Access+ hub services platform, they will lead operations that include:

• - Prescription Intake: Efficient handling of medication prescriptions.
• - Real-Time Eligibility and Coverage Checks: Instant verification for patient coverage to ensure therapy starts without unnecessary delays.
• - Patient Engagement: Automated engagement strategies utilizing data-driven approaches to maintain patient communication and support.

Meanwhile, Valeris will provide a range of comprehensive patient access services such as:

• - Benefit Verification: Thorough examination of both pharmacy and medical benefits for improved patient understanding.
• - Prior Authorization and Appeals Support: Assistance in navigating the bureaucratic processes to obtain necessary approvals for therapy.
• - Affordability Solutions: Helping patients manage costs associated with their therapies to prevent discontinuation of essential medications.
• - Patient Support Services: Offering ongoing support throughout the patient journey.

This coordination aims to enhance accountability, providing more visibility into patient outcomes for both health services and biopharmaceutical partners.

Targeted Areas for Impact

The collaboration will specifically impact four key areas, ensuring that the process from prescription to therapy initiation is expedited, access to medicines is improved, and overall patient engagement is maximized:
1. Accelerating Therapy Initiation: Streamlined processes will minimize delays, allowing patients to begin their therapies without unnecessary hold-ups.
2. Enhanced Access and Affordability: By integrating support solutions, the collaboration aims to reduce patient drop-offs and raise the initiation of therapy among patients.
3. Proactive Patient Support: Improved integration between digital pharmacy and patient services, employing AI and automation to enhance visibility and speed at scale.
4. Adaptability in a Changing Market: As the landscape of patient access swiftly shifts, this collaboration seeks to provide innovative solutions that are data-informed and focused on patients' needs.

Conclusion

This collaboration represents a forward-thinking approach in transforming how patients access medicines and services in today’s healthcare ecosystem. With Valeris’s experience in life sciences and Fuze Health’s technological edge, the partnership is set to pave a new path toward improved patient outcomes and streamlined care processes. As both companies align their strategies toward enhancing patient access, stakeholders in the healthcare industry can expect significant improvements that will ultimately benefit patients navigating their treatment journeys.